Blueprint Medicines Correlations

BPMC Stock  USD 94.15  2.47  2.56%   
The current 90-days correlation between Blueprint Medicines Corp and Coherus BioSciences is 0.13 (i.e., Average diversification). The correlation of Blueprint Medicines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Blueprint Medicines Correlation With Market

Very weak diversification

The correlation between Blueprint Medicines Corp and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Blueprint Medicines Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Moving together with Blueprint Stock

  0.77MDGL Madrigal PharmaceuticalsPairCorr

Moving against Blueprint Stock

  0.51JNJ Johnson Johnson Sell-off TrendPairCorr
  0.5PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.48EQ EquilliumPairCorr
  0.47TCHH Trustcash HoldingsPairCorr
  0.42TLK Telkom Indonesia TbkPairCorr
  0.39PG Procter GamblePairCorr
  0.39KO Coca Cola Aggressive PushPairCorr
  0.36HYMTF Hyundai MotorPairCorr
  0.35IBM International Business Fiscal Year End 22nd of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
HOOKLYRA
CHRSHOOK
CHRSLYRA
CINGWHOOK
CHRSCINGW
CVKDSABS
  
High negative correlations   
CHRSCVKD
CVKDHOOK
SABSCINGW
CVKDLYRA
CHRSSABS
CVKDCINGW

Risk-Adjusted Indicators

There is a big difference between Blueprint Stock performing well and Blueprint Medicines Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Blueprint Medicines' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Blueprint Medicines Corporate Management

Dr MBAChief OfficerProfile
Ariel HurleyPrincipal Accounting OfficerProfile
Tracey EsqChief VPProfile
Christina RossiChief Commercial OfficerProfile
Michael CPAChief OfficerProfile